Feasibility Study of Transit Dosimetry (TD) with an Electronic Portal Imaging Device (EPID) in volumetric arc therapy (VMAT) for head and neck cancer (HNC)

Introduction: The progress in radiotherapy treatment modalities, such as Intensity Modulated Radiotherapy (IMRT) and Volumetric Arc Therapy (VMAT), introduces considerable complexity. Consequently, the precision of dose delivery in treatment becomes crucial. This dosimetric investigation aims to int...

Full description

Saved in:
Bibliographic Details
Main Authors: ARVIND DIUNDI, KIRAN SHARMA, CHANDI BHATT, SANGEETA HAZARIKA
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2025-02-01
Series:Iranian Journal of Medical Physics
Subjects:
Online Access:https://ijmp.mums.ac.ir/article_25901_50ee661d233fff13592ab9846bf574e9.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850200625531322368
author ARVIND DIUNDI
KIRAN SHARMA
CHANDI BHATT
SANGEETA HAZARIKA
author_facet ARVIND DIUNDI
KIRAN SHARMA
CHANDI BHATT
SANGEETA HAZARIKA
author_sort ARVIND DIUNDI
collection DOAJ
description Introduction: The progress in radiotherapy treatment modalities, such as Intensity Modulated Radiotherapy (IMRT) and Volumetric Arc Therapy (VMAT), introduces considerable complexity. Consequently, the precision of dose delivery in treatment becomes crucial. This dosimetric investigation aims to integrate transit dosimetry into routine clinical procedures and assess outcomes using the gamma analysis methodology.Material and Methods: This dosimetric investigation selected a cohort comprising 30 patients diagnosed with head and neck cancer (HNC) and treated using TruebeamTM & HalcyonTM medical linear accelerators (Varian Medical Systems, Palo Alto, CA). Nine hundred forty-two treatment fluence maps were generated using transit dosimetry and evaluated with gamma analysis. The dosimetry was performed using amorphous silicon (a-Si 1000 and a-Si 1200) electronic portal imaging devices (EPIDs), with gamma analysis criteria of 2% dose difference (DD) and 2 mm distance to agreement (DTA), as well as 3% DD and 3 mm DTA.Results: Daily treatment consistency was assessed by establishing the initial-day fluence as the reference for the entire treatment regimen. In all instances, it was observed that the area gamma value was <1, exceeding 95% compliance when applying the 2%, 2 mm, and 3%, 3 mm criteria. This indicates a favourable agreement between the fluence of the reference day and subsequent treatment sessions throughout the course of treatment.Conclusion: The findings of this dosimetric investigation demonstrate the successful integration of transit dosimetry into routine clinical procedures, providing assurance in dose verification without imparting additional doses to patients. Consequently, this dosimetric approach exhibits potential efficacy for dose verification purposes within clinical settings.
format Article
id doaj-art-cc8145eace7f419e8aa0e04a7fe389f0
institution OA Journals
issn 2345-3672
language English
publishDate 2025-02-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Medical Physics
spelling doaj-art-cc8145eace7f419e8aa0e04a7fe389f02025-08-20T02:12:15ZengMashhad University of Medical SciencesIranian Journal of Medical Physics2345-36722025-02-01221283510.22038/ijmp.2025.78427.238725901Feasibility Study of Transit Dosimetry (TD) with an Electronic Portal Imaging Device (EPID) in volumetric arc therapy (VMAT) for head and neck cancer (HNC)ARVIND DIUNDI0KIRAN SHARMA1CHANDI BHATT2SANGEETA HAZARIKA3Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, IndiaGraphic Era Deemed to be University, Dehradun, Uttarakhand, IndiaSarvodaya Hospital &amp; Research Centre, Faridabad (Delhi/NCR), India 121006Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, IndiaIntroduction: The progress in radiotherapy treatment modalities, such as Intensity Modulated Radiotherapy (IMRT) and Volumetric Arc Therapy (VMAT), introduces considerable complexity. Consequently, the precision of dose delivery in treatment becomes crucial. This dosimetric investigation aims to integrate transit dosimetry into routine clinical procedures and assess outcomes using the gamma analysis methodology.Material and Methods: This dosimetric investigation selected a cohort comprising 30 patients diagnosed with head and neck cancer (HNC) and treated using TruebeamTM & HalcyonTM medical linear accelerators (Varian Medical Systems, Palo Alto, CA). Nine hundred forty-two treatment fluence maps were generated using transit dosimetry and evaluated with gamma analysis. The dosimetry was performed using amorphous silicon (a-Si 1000 and a-Si 1200) electronic portal imaging devices (EPIDs), with gamma analysis criteria of 2% dose difference (DD) and 2 mm distance to agreement (DTA), as well as 3% DD and 3 mm DTA.Results: Daily treatment consistency was assessed by establishing the initial-day fluence as the reference for the entire treatment regimen. In all instances, it was observed that the area gamma value was <1, exceeding 95% compliance when applying the 2%, 2 mm, and 3%, 3 mm criteria. This indicates a favourable agreement between the fluence of the reference day and subsequent treatment sessions throughout the course of treatment.Conclusion: The findings of this dosimetric investigation demonstrate the successful integration of transit dosimetry into routine clinical procedures, providing assurance in dose verification without imparting additional doses to patients. Consequently, this dosimetric approach exhibits potential efficacy for dose verification purposes within clinical settings.https://ijmp.mums.ac.ir/article_25901_50ee661d233fff13592ab9846bf574e9.pdftransit dosimetry invivo dosimetry gamma analysis epid
spellingShingle ARVIND DIUNDI
KIRAN SHARMA
CHANDI BHATT
SANGEETA HAZARIKA
Feasibility Study of Transit Dosimetry (TD) with an Electronic Portal Imaging Device (EPID) in volumetric arc therapy (VMAT) for head and neck cancer (HNC)
Iranian Journal of Medical Physics
transit dosimetry in
vivo dosimetry gamma analysis epid
title Feasibility Study of Transit Dosimetry (TD) with an Electronic Portal Imaging Device (EPID) in volumetric arc therapy (VMAT) for head and neck cancer (HNC)
title_full Feasibility Study of Transit Dosimetry (TD) with an Electronic Portal Imaging Device (EPID) in volumetric arc therapy (VMAT) for head and neck cancer (HNC)
title_fullStr Feasibility Study of Transit Dosimetry (TD) with an Electronic Portal Imaging Device (EPID) in volumetric arc therapy (VMAT) for head and neck cancer (HNC)
title_full_unstemmed Feasibility Study of Transit Dosimetry (TD) with an Electronic Portal Imaging Device (EPID) in volumetric arc therapy (VMAT) for head and neck cancer (HNC)
title_short Feasibility Study of Transit Dosimetry (TD) with an Electronic Portal Imaging Device (EPID) in volumetric arc therapy (VMAT) for head and neck cancer (HNC)
title_sort feasibility study of transit dosimetry td with an electronic portal imaging device epid in volumetric arc therapy vmat for head and neck cancer hnc
topic transit dosimetry in
vivo dosimetry gamma analysis epid
url https://ijmp.mums.ac.ir/article_25901_50ee661d233fff13592ab9846bf574e9.pdf
work_keys_str_mv AT arvinddiundi feasibilitystudyoftransitdosimetrytdwithanelectronicportalimagingdeviceepidinvolumetricarctherapyvmatforheadandneckcancerhnc
AT kiransharma feasibilitystudyoftransitdosimetrytdwithanelectronicportalimagingdeviceepidinvolumetricarctherapyvmatforheadandneckcancerhnc
AT chandibhatt feasibilitystudyoftransitdosimetrytdwithanelectronicportalimagingdeviceepidinvolumetricarctherapyvmatforheadandneckcancerhnc
AT sangeetahazarika feasibilitystudyoftransitdosimetrytdwithanelectronicportalimagingdeviceepidinvolumetricarctherapyvmatforheadandneckcancerhnc